A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome

by Dennis Poon, Graham R. Law, Giles Major, H. Jervoise N. Andreyev
Published 2022-02-01

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome

by Ryan Marsh, Claudio Dos Santos, Liam Hanson, Christabella Ng, Giles Major, Alan R. Smyth, Damian Rivett, Christopher van der Gast
Published 2023-10-01

The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls

by Jonna Jalanka, Giles Major, Kathryn Murray, Gulzar Singh, Adam Nowak, Caroline Kurtz, Inmaculada Silos-Santiago, Jeffrey M. Johnston, Willem M. de Vos, Robin Spiller
Published 2019-01-01

A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes: a pilot study. [version 2; peer review:...

by Christabella Ng, Helen Barr, Caroline Hoad, Neele S Dellschaft, Robin Spiller, Luca Marciani, Alan R Smyth, Trevor Hill, Colin Crooks, Jochen G Mainz, Alex Menys, Giles Major, Penny A. Gowland
Published 2024-03-01